Identification of human endogenous retroviral antigen and its association with diseases

人内源性逆转录病毒抗原的鉴定及其与疾病的关系

基本信息

  • 批准号:
    03670184
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1991
  • 资助国家:
    日本
  • 起止时间:
    1991 至 1992
  • 项目状态:
    已结题

项目摘要

To identify the presence of human endogenous retroviral gene product in human tissue, we prepared several recombinant proteins by using gene technology. One of env gene product derived from human endogenous retrovirus like genomic DNA was produced in E. coli. We purified this recombinant protein and immunized to rabbit produce antibody. By using antibody against recombinant env gene product we observed the presence of human endogenous retroviral antigen in the placenta. We detected natural antibody against this protein in the patient sera from systemic lupus erythematosus. Next we prepared recombinant protein using Baculovirus vector system. We modified the genomic DNA encoding gag region of human endogenous retrovirus like DNA by site mutagenesis to produce long-sized openreading frame. By using this modified DNA we obtained recombinat protein corresponding gag protein fo murine of feline leukemia virus. When developing Western hybridization of this recombinant protein with anti-murine leukemia viral p30 serum, the recombinat protein showed strong positivity. These results indicated the origin of human endogenous retrovirus like sequences are derived same origin with murine leukemia virus genome.Our results may help to understand the association between human endogenous retrovirus and human diseases in future.
为了鉴定人内源性逆转录病毒基因产物在人体组织中的存在,我们利用基因技术制备了几种重组蛋白。从人内源性逆转录病毒样基因组DNA中获得一种env基因产物。我们纯化了该重组蛋白,并免疫兔产生抗体。利用重组env基因产物的抗体,我们观察到胎盘中存在人内源性逆转录病毒抗原。我们在系统性红斑狼疮患者血清中检测到该蛋白的天然抗体。接下来,我们利用杆状病毒载体系统制备重组蛋白。我们通过点突变的方法对编码人内源性逆转录病毒类DNA的基因组DNA进行了修饰,得到了大小较长的开放阅读框。利用修饰后的DNA,我们获得了猫白血病病毒小鼠的重组蛋白对应的Gag蛋白。将该重组蛋白与小鼠白血病病毒P30抗血清进行Western杂交,结果显示重组蛋白呈强阳性。这些结果表明人类内源性逆转录病毒样序列的起源与小鼠白血病病毒基因同源,我们的结果可能有助于进一步了解人类内源性逆转录病毒与人类疾病之间的关系。

项目成果

期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
SHIGEMOTO et al: "Expression and stracture of serum gp 70 as an acute phase protein in NZB micl" Molecular Immunology. 29. 573-582 (1992)
SHIGEMOTO 等人:“NZB micl 中血清 gp 70 作为急性期蛋白的表达和结构”分子免疫学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kitamura,M., Shirasawa,T., Mitarai,T., Muramatsu,T., and Maruyama,N: "A retinoic acid responsive gene, MK, is preferentially expressed in the proximal tubules of the kidney and human tumor cell lines" American J. Pathology.
Kitamura,M.、Shirasawa,T.、Mitarai,T.、Muramatsu,T. 和 Maruyama,N:“视黄酸反应基因 MK 优先在肾和人类肿瘤细胞系的近端小管中表达”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shigemoto et al.: "Expression and structure of serum gp70 as an acute phase protein in NZB mice" Molecular lmmunology. 29. 573-582 (1992)
Shigemoto 等人:“NZB 小鼠中血清 gp70 作为急性期蛋白的表达和结构”分子免疫学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Itoh,Y et al.: "The strain-dependent constitutive expression of murine serum amyloid-P component is regulated at the transeriptional level." Biochimica et Biophysica Acata. 1131. 261-269 (1992)
Itoh,Y 等人:“鼠血清淀粉样蛋白 P 成分的菌株依赖性组成型表达在转录水平上受到调节。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARUYAMA Naoki其他文献

MARUYAMA Naoki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARUYAMA Naoki', 18)}}的其他基金

Clinical application and biochemical analysis of the citrullinated proteins which catalyzed by peptidylarginine deiminase
肽精氨酸脱亚氨酶催化瓜氨酸化蛋白的临床应用及生化分析
  • 批准号:
    23590441
  • 财政年份:
    2011
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study of a Refuel System with High Efficiency to Process Waste Material using Circulation-Type Superheated Steam
循环式过热蒸汽高效处理废弃物补料系统的研究
  • 批准号:
    23560228
  • 财政年份:
    2011
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Moluecular analysis of the lesion induced by SMP30
SMP30诱导病变的分子分析
  • 批准号:
    12670224
  • 财政年份:
    2000
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Expression of human endogenous retrovirus gene in tumor cells
人内源性逆转录病毒基因在肿瘤细胞中的表达
  • 批准号:
    06670246
  • 财政年份:
    1994
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Development of an innovative recombinant protein vaccine against Aeromonas veronii in European seabass using "omics" technologies (AeroVeroVacc)
使用“组学”技术开发针对欧洲鲈鱼维氏气单胞菌的创新重组蛋白疫苗 (AeroVeroVacc)
  • 批准号:
    EP/Y026454/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Fellowship
I-Corps: Accelerating recombinant protein screening
I-Corps:加速重组蛋白筛选
  • 批准号:
    2328626
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Standard Grant
Integrating data intelligence and hybrid modelling to develop continuous CHO cell lines for recombinant protein production
整合数据智能和混合建模来开发用于重组蛋白生产的连续 CHO 细胞系
  • 批准号:
    2898720
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Studentship
Quantum-Accelerated Recombinant Protein Drug Embedding Frameworks (QARPDEF)
量子加速重组蛋白药物嵌入框架 (QARPDEF)
  • 批准号:
    10082522
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Small Business Research Initiative
Greener, more sustainable platforms for high-value recombinant protein production
更环保、更可持续的高价值重组蛋白生产平台
  • 批准号:
    EP/X025926/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Research Grant
ProNaGen: Engineering of Recombinant Protein Nanosheet-Based Bioemulsions for Next Generation Bioprocessing and Biomanufacturing
ProNaGen:用于下一代生物加工和生物制造的基于重组蛋白纳米片的生物乳液的工程
  • 批准号:
    EP/Y032667/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Research Grant
Effect of recombinant protein expression on baculovirus budded virus structure and infectivity
重组蛋白表达对杆状病毒芽胞病毒结构和感染性的影响
  • 批准号:
    ST/Y000498/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Research Grant
Novel recombinant protein immunoassays for the diagnosis and monitoring of toxocariasis in children living in the United States.
用于诊断和监测美国儿童弓蛔虫病的新型重组蛋白免疫分析。
  • 批准号:
    10742436
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Large Scale Expansion of Mesenchymal Stromal Cells using Dissolvable Microcarriers and Animal Product Free Recombinant Protein Coatings
使用可溶性微载体和无动物产品的重组蛋白涂层大规模扩增间充质基质细胞
  • 批准号:
    569481-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Generation of Syn-PG1 expressing yeast and the recombinant protein production
表达 Syn-PG1 的酵母的产生和重组蛋白的生产
  • 批准号:
    571827-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
    University Undergraduate Student Research Awards
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了